Professional Bio
B.S. with Distinction and Departmental Honors in Biological Sciences and Chemistry, Stanford University, 1989.
Medical Scientist Training Program trainee (M.D. 1997, Ph.D., 1996), Duke University School of Medicine.
Intern in Internal Medicine, University of North Carolina Hospitals, 1997-8.
Resident in Internal Medicine, Barnes-Jewish Hospitals, 1998-2000.
Fellowship in Infectious Diseases, University of North Carolina Hospitals, 2000-2003.
Medical Officer, Division on Antiviral Products, U.S. Food and Drug Administration, 2003-2005.
Associate Professor in Medicine/Infectious Diseases, University of Rochester School of Medicine and Dentistry, 2012-present.
Assistant Professor in Medicine/Infectious Diseases, University of Rochester School of Medicine and Dentistry, 2005-2012.
Attending Physician, Infectious Diseases, Rochester General Hospital, 2005-present.
Research Bio
My current research interests include: 1) host immune response and preclinical vaccine development against respiratory syncytial virus (RSV) and related respiratory viruses; 2) clinical studies of respiratory viruses and bacterial infections in adults; and 3) development of novel antimicrobial agents against Acinetobacter baumanni and other Gram-negative ESKAPE pathogens.
Relevant publications:
1. Murata Y, Catherman SC. Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice. Vaccine 30: 5382-8, 2012.
2. Murata Y, Lightfoote PM, Biear JN, Falsey AR, Walsh EE. Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein. Vaccine 28: 6242-6, 2010.
3. Murata Y, Lightfoote PM, Falsey AR, Walsh EE. Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein. Clin Vaccine Immunol 17: 695-697, 2010.
4. Murata Y, Lightfoote PM, Rose RC, Walsh EE. Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres. Virol J 2009; 6: 81.
5. .Murata Y, Walsh EE, Falsey, AR. Pulmonary complications of inter-pandemic influenza A in hospitalized adults. J Infect Dis 195: 1029-1037, 2007.
6 .Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 167: 354-360, 2007.
Review Articles (Peer Reviewed):
1.Murata Y and Falsey AR. Respiratory syncytial virus infection in adults. Antiviral Therapy 12: 659-670, 2007.
2.Murata Y. Respiratory syncytial virus infection in adults. Curr Opin Pulm Med 14: 235-240, 2008.
Book chapters:
1.Murata Y and Falsey AR. RSV Infection in Elderly Adults. In: Cane P ed., Respiratory Syncytial Virus, Perspectives in Medical Virology Vol. 14 (Elsevier, Oxford, UK, 2007), pp. 163-181.
2012
Murata, Y; Catherman, S. "Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice". Vaccine. 2012; . |
2010 Aug 31
Murata Y, Lightfoote PM, Biear JN, Falsey AR, Walsh EE. "Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein." Vaccine. 2010 Aug 31; 28(38):6242-6. Epub 2010 Jul 23. |
2010
Murata Y,; Lightfoote, P.M.; Falsey, A.R.; Walsh E.E. "Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein". Clin Vaccine Immunol. 2010; 17: 695-7. |
2009
Murata, Y.; Lightfoote, P.M.; Rose, R.C.; Walsh, E.E. "Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres". Virol J. 2009; 6: 81. |
2007 Apr 1
Murata Y, Walsh EE, Falsey AR. "Pulmonary complications of interpandemic influenza A in hospitalized adults." The Journal of infectious diseases. 2007 Apr 1; 195(7):1029-37. Epub 2007 Feb 15. |
